Benitec Biopharma Inc.
BNTC
$13.11
$0.534.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.27% | 92.16% | 632.40% | 284.23% | 162.30% |
| Total Receivables | 75.00% | -85.59% | -94.34% | -96.23% | -92.45% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.68% | 21.71% | 129.94% | 3.10% | -11.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 76.56% | 79.37% | 384.62% | 342.86% | 392.31% |
| Total Current Assets | 39.14% | 90.65% | 624.00% | 278.50% | 158.73% |
|
|
|||||
| Total Current Assets | 39.14% | 90.65% | 624.00% | 278.50% | 158.73% |
| Net Property, Plant & Equipment | 143.85% | 120.71% | 105.75% | -36.14% | -32.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.41% | -4.60% | -4.26% | -36.79% | -26.36% |
| Total Assets | 39.63% | 90.75% | 601.44% | 270.29% | 154.22% |
|
|
|||||
| Total Accounts Payable | -69.99% | -85.12% | -46.87% | -77.36% | -40.90% |
| Total Accrued Expenses | -1.91% | -19.01% | 28.53% | 12.58% | 28.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 96.21% | 24.65% | 18.49% | -52.10% | -24.64% |
| Total Finance Division Other Current Liabilities | -77.08% | -72.63% | 223.98% | -24.81% | 25.58% |
| Total Other Current Liabilities | -77.08% | -72.63% | 223.98% | -24.81% | 25.58% |
| Total Current Liabilities | -55.52% | -63.40% | 104.42% | -46.24% | 0.42% |
|
|
|||||
| Total Current Liabilities | -55.52% | -63.40% | 104.42% | -46.24% | 0.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 888.71% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -47.15% | -53.71% | 118.32% | -46.85% | -3.18% |
|
|
|||||
| Common Stock & APIC | 27.26% | 36.88% | 57.32% | 41.73% | 32.28% |
| Retained Earnings | -21.41% | -19.93% | -14.66% | -12.20% | -12.35% |
| Treasury Stock & Other | 24.47% | 5.94% | 14.25% | 27.73% | -27.31% |
| Total Common Equity | 45.84% | 105.92% | 748.43% | 390.89% | 187.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.84% | 105.92% | 748.43% | 390.89% | 187.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.84% | 105.92% | 748.43% | 390.89% | 187.70% |
|
|
|||||